Axoft
PrivateLast Round
Series A
Apr 29, 2026
Est. Valuation
$33M
Total Funding Raised
$63M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Axoft is a neurotechnology company that develops implantable Brain-Computer Interfaces (iBCIs) using novel, ultra-soft materials to treat neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Data as a Service, Government Contracts
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axoft Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Axoft Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 29, 2026 | ||||
| Seed | Oct 18, 2022 |
Axoft Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blindspot Ventures | Seed |
| Engine Ventures | Seed |
| Hillhouse Investment | Series A |
| Project 11 Ventures | Seed |
| Taihill Venture | Seed |
| Stanford University | Series A |
| Reform Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Raised $55M led by C.P. Group Innovation.
- Apr 1, 2026
Introduced 'Fleuron polymers' product line, hiring chemist for development.
Axoft Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axoft's valuation, stock price, and market status.